The other, forgotten genome: mitochondrial DNA and mental disorders

被引:54
作者
Kato, T [1 ]
机构
[1] RIKEN, Brain Sci Inst, Lab Mol Dynam Mental Disorders, Wako, Saitama 3510198, Japan
关键词
bipolar disorder; mitochondria; molecular genetics; electron transport chain; postmortem brain; schizophrenia;
D O I
10.1038/sj.mp.4000926
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This paper summarizes recent research on mitochondrial DNA (mtDNA)-which might be described as the 'other, forgotten genome'. Recent studies suggest the possible pathophysiological significance of mtDNA in schizophrenia and neurodegenerative and mood disorders. Decreased activity of the mitochondrial electron transport chain has been implicated in both Parkinson's and Alzheimer's disease and while age-related accumulation of mtDNA deletions has been suggested as a possible cause, there is no concrete evidence that particular mtDNA polymorphisms are responsible. In schizophrenia, the activity and/or mRNA expression of complex IV are involved, but the direction of the alteration is not the same and there is no evidence linking schizophrenia with mtDNA. In bipolar disorder, there is some evidence of parent-of-origin effects and association with mtDNA polymorphisms but further investigation is needed to elucidate the role of mtDNA in mental disorders.
引用
收藏
页码:625 / 633
页数:9
相关论文
共 132 条
[91]   Fragile mitochondrial DNA: The missing link in the apoptotic neuronal cell death in Parkinson's disease [J].
Ozawa, T ;
Hayakawa, M ;
Katsumata, K ;
Yoneda, M ;
Ikebe, S ;
Mizuno, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 235 (01) :158-161
[92]   MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC-ACIDOSIS, AND STROKELIKE EPISODES - A DISTINCTIVE CLINICAL SYNDROME [J].
PAVLAKIS, SG ;
PHILLIPS, PC ;
DIMAURO, S ;
DEVIVO, DC ;
ROWLAND, LP .
ANNALS OF NEUROLOGY, 1984, 16 (04) :481-488
[93]   IS A POINT MUTATION IN THE MITOCHONDRIAL ND2 GENE ASSOCIATED WITH ALZHEIMERS-DISEASE [J].
PETRUZZELLA, V ;
CHEN, X ;
SCHON, EA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 186 (01) :491-497
[94]  
Prayson RA, 1998, ARCH PATHOL LAB MED, V122, P978
[95]   Mitochondrial function is differentially altered in the basal ganglia of chronic schizophrenics [J].
Prince, JA ;
Blennow, K ;
Gottfries, CG ;
Karlsson, I ;
Oreland, L .
NEUROPSYCHOPHARMACOLOGY, 1999, 21 (03) :372-379
[96]   Normalization of cytochrome-c oxidase activity in the rat brain by neuroleptics after chronic treatment with PCP or methamphetamine [J].
Prince, JA ;
Yassin, MS ;
Oreland, L .
NEUROPHARMACOLOGY, 1997, 36 (11-12) :1665-1678
[97]   Putamen mitochondrial energy metabolism is highly correlated to emotional and intellectual impairment in schizophrenics [J].
Prince, JA ;
Harro, J ;
Blennow, K ;
Gottfries, CG ;
Oreland, L .
NEUROPSYCHOPHARMACOLOGY, 2000, 22 (03) :284-292
[98]  
Prince JA, 1997, J PHARMACOL EXP THER, V280, P261
[99]   Brain activation in normal subjects and in patients affected by mitochondrial disease without clinical central nervous system involvement: A phosphorus magnetic resonance spectroscopy study [J].
Rango, M ;
Bozzali, M ;
Prelle, A ;
Scarlato, G ;
Bresolin, N .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2001, 21 (01) :85-91
[100]   Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization [J].
Sawa, A ;
Wiegand, GW ;
Cooper, J ;
Margolis, RL ;
Sharp, AH ;
Lawler, JF ;
Greenamyre, JT ;
Snyder, SH ;
Ross, CA .
NATURE MEDICINE, 1999, 5 (10) :1194-1198